Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2012

Open Access 01-12-2012 | Research

Why do smokers diagnosed with COPD not quit smoking? - a qualitative study

Authors: Britt-Marie Eklund, Siv Nilsson, Linnea Hedman, Inger Lindberg

Published in: Tobacco Induced Diseases | Issue 1/2012

Login to get access

Abstract

Background

Chronic Obstructive Pulmonary Disease (COPD) is currently one of the most widespread chronic lung diseases and a growing cause of suffering and mortality worldwide. It is predicted to become the third leading cause of death in the near future. Smoking is the most important risk factor, and about 50% of smokers develop COPD. Smoking cessation is the most important way to improve prognosis. The aim of the study was to describe difficulties of smoking cessation experienced by individuals with COPD who are unable to stop smoking.

Methods

Ten smokers (five women) with COPD, GOLD stage II, participated in semi-structured interviews in 2010. The data were analyzed using qualitative content analysis. The participants were recruited from the Obstructive Lung Disease in Northern Sweden (OLIN) studies.

Results

The participants lives were governed by a lifelong smoking habit that was difficult to break although they had knowledge about the harmful effects and the consequences of COPD. The participants described incidents in their lives as reasons for never finding the time to quit smoking. Demands to quit smoking from other people could lead to continued smoking or get them started again after cessation as they did not want to be patronized. They wanted to receive support from relatives and care providers but they wanted to make the decision to quit on their own.

Conclusion

For successful smoking cessation, it is important to understand the difficulties smokers are experiencing that influence their efforts to quit smoking. To achieve a successful lasting smoking cessation it might be more effective to first ensure that the smoker has the right internal motivation to make the decision to quit, then assist with smoking cessation.
Literature
1.
go back to reference Global Strategy for the Diagnosis, Management and Prevention of COPD: Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011, Available from:http://www.goldcopd.org/. Accessed september 2012. Global Strategy for the Diagnosis, Management and Prevention of COPD: Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011, Available from:http://​www.​goldcopd.​org/​. Accessed september 2012.
2.
go back to reference Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B: Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005, 127: 1544-52. 10.1378/chest.127.5.1544.CrossRefPubMed Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B: Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005, 127: 1544-52. 10.1378/chest.127.5.1544.CrossRefPubMed
3.
go back to reference Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006, 100: 264-72. 10.1016/j.rmed.2005.04.029.CrossRefPubMed Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2006, 100: 264-72. 10.1016/j.rmed.2005.04.029.CrossRefPubMed
4.
go back to reference Jansson S, Andersson F, Borg S, Ericsson A, Jönsson E, Lundbäck B: Costs of COPD in Sweden according to disease severity. Chest. 2002, 122: 1994-2002. 10.1378/chest.122.6.1994.CrossRefPubMed Jansson S, Andersson F, Borg S, Ericsson A, Jönsson E, Lundbäck B: Costs of COPD in Sweden according to disease severity. Chest. 2002, 122: 1994-2002. 10.1378/chest.122.6.1994.CrossRefPubMed
5.
go back to reference Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson A, Jönsson E, Larsson L, Andersson S, Sandström T, Larsson K: Not 15 but 50% of smokers develop COPD?–Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003, 97: 115-22. 10.1053/rmed.2003.1446.CrossRefPubMed Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson A, Jönsson E, Larsson L, Andersson S, Sandström T, Larsson K: Not 15 but 50% of smokers develop COPD?–Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003, 97: 115-22. 10.1053/rmed.2003.1446.CrossRefPubMed
6.
go back to reference Godtfredsen NS, Prescott E: Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. Clin Respir J. 2011, 5: 187-194. 10.1111/j.1752-699X.2011.00262.x.CrossRefPubMed Godtfredsen NS, Prescott E: Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. Clin Respir J. 2011, 5: 187-194. 10.1111/j.1752-699X.2011.00262.x.CrossRefPubMed
7.
go back to reference Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O’Hara P: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994, 272: 1497-1505. 10.1001/jama.1994.03520190043033.CrossRefPubMed Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA, Enright PL, Kanner RE, O’Hara P: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994, 272: 1497-1505. 10.1001/jama.1994.03520190043033.CrossRefPubMed
8.
go back to reference Fletcher CM: The Natural History of Chronic Bronchitis and Emphysema: An Eight-Year Study of Early Chronic Obstructive Lung Disease in Working Men in London. 1976, Oxford. New York: Oxford University Press Fletcher CM: The Natural History of Chronic Bronchitis and Emphysema: An Eight-Year Study of Early Chronic Obstructive Lung Disease in Working Men in London. 1976, Oxford. New York: Oxford University Press
9.
go back to reference Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A: Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax. 2001, 56: 703-707. 10.1136/thorax.56.9.703.PubMedCentralCrossRefPubMed Pelkonen M, Notkola IL, Tukiainen H, Tervahauta M, Tuomilehto J, Nissinen A: Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax. 2001, 56: 703-707. 10.1136/thorax.56.9.703.PubMedCentralCrossRefPubMed
10.
go back to reference Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA: The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med. 2009, 24: 457-463. 10.1007/s11606-009-0907-y.PubMedCentralCrossRefPubMed Au DH, Bryson CL, Chien JW, Sun H, Udris EM, Evans LE, Bradley KA: The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med. 2009, 24: 457-463. 10.1007/s11606-009-0907-y.PubMedCentralCrossRefPubMed
11.
go back to reference Stratelis G, Molstad S, Jakobsson P, Zetterstrom O: The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006, 24: 133-139. 10.1080/02813430600819751.CrossRefPubMed Stratelis G, Molstad S, Jakobsson P, Zetterstrom O: The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006, 24: 133-139. 10.1080/02813430600819751.CrossRefPubMed
12.
go back to reference Quist Paulsen P: Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients. Clin Respir J. 2008, 2: 4-10. 10.1111/j.1752-699X.2007.00038.x.CrossRefPubMed Quist Paulsen P: Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients. Clin Respir J. 2008, 2: 4-10. 10.1111/j.1752-699X.2007.00038.x.CrossRefPubMed
13.
go back to reference Tonnesen P, Mikkelsen K, Bremann L: Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest. 2006, 130: 334-342. 10.1378/chest.130.2.334.CrossRefPubMed Tonnesen P, Mikkelsen K, Bremann L: Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest. 2006, 130: 334-342. 10.1378/chest.130.2.334.CrossRefPubMed
14.
go back to reference Fagerstrom KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, Puska P, Ramstrom L, Zatonski W: Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 1996, 5: 52-56. 10.1136/tc.5.1.52.PubMedCentralCrossRefPubMed Fagerstrom KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, Puska P, Ramstrom L, Zatonski W: Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 1996, 5: 52-56. 10.1136/tc.5.1.52.PubMedCentralCrossRefPubMed
15.
go back to reference Davila EP, Zhao W, Byrne M, Webb M, Huang Y, Arheart K, Dietz N, Caban-Martinez A, Parker D, Lee DJ: Correlates of smoking quit attempts: Florida Tobacco Callback Survey, 2007. Tob Induc Dis. 2009, 5: 10-10.1186/1617-9625-5-10.PubMedCentralCrossRefPubMed Davila EP, Zhao W, Byrne M, Webb M, Huang Y, Arheart K, Dietz N, Caban-Martinez A, Parker D, Lee DJ: Correlates of smoking quit attempts: Florida Tobacco Callback Survey, 2007. Tob Induc Dis. 2009, 5: 10-10.1186/1617-9625-5-10.PubMedCentralCrossRefPubMed
16.
go back to reference Wilson JS, Fitzsimons D, Bradbury I, Stuart Elborn J: Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial. Int J Nurs Stud. 2008, 45: 508-517. 10.1016/j.ijnurstu.2006.10.001.CrossRefPubMed Wilson JS, Fitzsimons D, Bradbury I, Stuart Elborn J: Does additional support by nurses enhance the effect of a brief smoking cessation intervention in people with moderate to severe chronic obstructive pulmonary disease? A randomised controlled trial. Int J Nurs Stud. 2008, 45: 508-517. 10.1016/j.ijnurstu.2006.10.001.CrossRefPubMed
17.
go back to reference Wilson JS, Elborn JS, Fitzsimons D: ‘It’s not worth stopping now’: why do smokers with chronic obstructive pulmonary disease continue to smoke? A qualitative study. J Clin Nurs. 2011, 20: 819-827. 10.1111/j.1365-2702.2010.03319.x.CrossRefPubMed Wilson JS, Elborn JS, Fitzsimons D: ‘It’s not worth stopping now’: why do smokers with chronic obstructive pulmonary disease continue to smoke? A qualitative study. J Clin Nurs. 2011, 20: 819-827. 10.1111/j.1365-2702.2010.03319.x.CrossRefPubMed
18.
go back to reference Lindberg A, Lundbäck B: The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality. Clin Respir J. 2008, 2 (Suppl 1): 64-71.CrossRefPubMed Lindberg A, Lundbäck B: The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality. Clin Respir J. 2008, 2 (Suppl 1): 64-71.CrossRefPubMed
19.
go back to reference Graneheim UH, Lundman B: Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004, 24: 105-112. 10.1016/j.nedt.2003.10.001.CrossRefPubMed Graneheim UH, Lundman B: Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004, 24: 105-112. 10.1016/j.nedt.2003.10.001.CrossRefPubMed
20.
go back to reference Elo S, Kyngäs H: The qualitative content analysis process. J Adv Nurs. 2007, 62: 107-115.CrossRef Elo S, Kyngäs H: The qualitative content analysis process. J Adv Nurs. 2007, 62: 107-115.CrossRef
21.
go back to reference O’Loughlin J, Kishchuk N, DiFranza J, Tremblay M, Paradis G: The hardest thing is the habit: a qualitative investigation of adolescent smokers’ experience of nicotine dependence. Nicotine Tob Res. 2002, 4: 201-209. 10.1080/14622200210123000.CrossRefPubMed O’Loughlin J, Kishchuk N, DiFranza J, Tremblay M, Paradis G: The hardest thing is the habit: a qualitative investigation of adolescent smokers’ experience of nicotine dependence. Nicotine Tob Res. 2002, 4: 201-209. 10.1080/14622200210123000.CrossRefPubMed
22.
go back to reference Hu MC, Davies M, Kandel DB: Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. Am J Public Health. 2006, 96: 299-308. 10.2105/AJPH.2004.057232.PubMedCentralCrossRefPubMed Hu MC, Davies M, Kandel DB: Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. Am J Public Health. 2006, 96: 299-308. 10.2105/AJPH.2004.057232.PubMedCentralCrossRefPubMed
23.
go back to reference Van Gucht D, Van den Bergh O, Beckers T, Vansteenwegen D: Smoking behavior in context: where and when do people smoke?. J Behav Ther Exp Psychiatry. 2010, 41: 172-177. 10.1016/j.jbtep.2009.12.004.CrossRefPubMed Van Gucht D, Van den Bergh O, Beckers T, Vansteenwegen D: Smoking behavior in context: where and when do people smoke?. J Behav Ther Exp Psychiatry. 2010, 41: 172-177. 10.1016/j.jbtep.2009.12.004.CrossRefPubMed
24.
go back to reference Kouvonen A, Kivimaki M, Virtanen M, Pentti J, Vahtera J: Work stress, smoking status, and smoking intensity: an observational study of 46,190 employees. J Epidemiol Community Health. 2005, 59: 63-69. 10.1136/jech.2004.019752.PubMedCentralCrossRefPubMed Kouvonen A, Kivimaki M, Virtanen M, Pentti J, Vahtera J: Work stress, smoking status, and smoking intensity: an observational study of 46,190 employees. J Epidemiol Community Health. 2005, 59: 63-69. 10.1136/jech.2004.019752.PubMedCentralCrossRefPubMed
25.
go back to reference Pisinger C, Jorgensen T: Weight concerns and smoking in a general population: the Inter99 study. Prev Med. 2007, 44: 283-289. 10.1016/j.ypmed.2006.11.014.CrossRefPubMed Pisinger C, Jorgensen T: Weight concerns and smoking in a general population: the Inter99 study. Prev Med. 2007, 44: 283-289. 10.1016/j.ypmed.2006.11.014.CrossRefPubMed
26.
go back to reference Hilberink SR, Jacobs JE, Schlosser M, Grol RP, de Vries H: Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ Couns. 2006, 61: 449-457. 10.1016/j.pec.2005.05.012.CrossRefPubMed Hilberink SR, Jacobs JE, Schlosser M, Grol RP, de Vries H: Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ Couns. 2006, 61: 449-457. 10.1016/j.pec.2005.05.012.CrossRefPubMed
27.
go back to reference Wagena EJ, Kant I, Huibers MJ, van Amelsvoort LG, Swaen GM, Wouters EF, van Schayck CP: Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes. Eur J Epidemiol. 2004, 19: 147-153.CrossRefPubMed Wagena EJ, Kant I, Huibers MJ, van Amelsvoort LG, Swaen GM, Wouters EF, van Schayck CP: Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes. Eur J Epidemiol. 2004, 19: 147-153.CrossRefPubMed
28.
go back to reference Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S: 2006. Respir Med. 2006, 100: 1767-1774. 10.1016/j.rmed.2006.01.026.CrossRefPubMed Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S: 2006. Respir Med. 2006, 100: 1767-1774. 10.1016/j.rmed.2006.01.026.CrossRefPubMed
29.
go back to reference Yang T, Fisher KJ, Li F, Danaher BG: Attitudes to smoking cessation and triggers to relapse among Chinese male smokers. BMC Publ Health. 2006, 6: 65-10.1186/1471-2458-6-65.CrossRef Yang T, Fisher KJ, Li F, Danaher BG: Attitudes to smoking cessation and triggers to relapse among Chinese male smokers. BMC Publ Health. 2006, 6: 65-10.1186/1471-2458-6-65.CrossRef
31.
go back to reference Vangeli E, West R: Sociodemographic differences in triggers to quit smoking: findings from a national survey. Tob Control. 2008, 17: 410-415. 10.1136/tc.2008.025650.CrossRefPubMed Vangeli E, West R: Sociodemographic differences in triggers to quit smoking: findings from a national survey. Tob Control. 2008, 17: 410-415. 10.1136/tc.2008.025650.CrossRefPubMed
32.
go back to reference Wells S, de Lusignan S: Does screening for loss of lung function help smokers give up?. Br J Nurs. 2003, 12: 744-750.CrossRefPubMed Wells S, de Lusignan S: Does screening for loss of lung function help smokers give up?. Br J Nurs. 2003, 12: 744-750.CrossRefPubMed
34.
go back to reference Vogt F, Hall S, Marteau TM: Examining why smokers do not want behavioral support with stopping smoking. Patient Educ Couns. 2010, 79: 160-166. 10.1016/j.pec.2009.10.007.CrossRefPubMed Vogt F, Hall S, Marteau TM: Examining why smokers do not want behavioral support with stopping smoking. Patient Educ Couns. 2010, 79: 160-166. 10.1016/j.pec.2009.10.007.CrossRefPubMed
35.
go back to reference May S, West R, Hajek P, McEwen A, McRobbie H: Social support and success at stopping smoking. J Smok Cessat. 2007, 2: 47-53.CrossRef May S, West R, Hajek P, McEwen A, McRobbie H: Social support and success at stopping smoking. J Smok Cessat. 2007, 2: 47-53.CrossRef
36.
go back to reference Holloway I, Wheeler S: Qualitative Research in Nursing and Healthcare. 2010, Wiley-Blackwell, Chichester, West Sussex: Ames, Iowa, 2010 Holloway I, Wheeler S: Qualitative Research in Nursing and Healthcare. 2010, Wiley-Blackwell, Chichester, West Sussex: Ames, Iowa, 2010
37.
go back to reference Polit D, Beck C: Developing a Sampling Plan. Nursing Research. 2008, Philadelphia: Lippincott Williams and Wilkins, 9 Polit D, Beck C: Developing a Sampling Plan. Nursing Research. 2008, Philadelphia: Lippincott Williams and Wilkins, 9
Metadata
Title
Why do smokers diagnosed with COPD not quit smoking? - a qualitative study
Authors
Britt-Marie Eklund
Siv Nilsson
Linnea Hedman
Inger Lindberg
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2012
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-10-17

Other articles of this Issue 1/2012

Tobacco Induced Diseases 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.